Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.930
+0.100 (5.46%)
Mar 16, 2026, 10:26 AM EDT - Market open
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $39.94 million as of March 16, 2026. Its market cap has increased by 30.74% in one year.
Market Cap
39.94M
Enterprise Value
27.81M
1-Year Change
30.74%
Ranking
Category
Stock Price
$1.93
Market Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $39.94M, a decrease of -93.67%. That is a compound annual growth rate of -42.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 11.26M | 10.91% |
| Dec 31, 2025 | 10.16M | -70.24% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
| Mar 17, 2021 | 631.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sensei Biotherapeutics | 40.85M |
| Palatin Technologies | 40.74M |
| CervoMed | 39.32M |
| Veru Inc. | 38.52M |
| Werewolf Therapeutics | 37.85M |
| Xilio Therapeutics | 37.47M |
| Tvardi Therapeutics | 36.77M |
| Evaxion | 36.45M |